• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将呼吸困难12量表应用于葡萄牙语COPD患者的验证。

Validation of the dyspnoea-12 scale into Portuguese speaking COPD patients.

作者信息

Simsic Aline Aparecida, Yorke Janelle, Regueiro Eloisa Gatti, Di Lorenzo Valeria Pires, Baddini-Martinez José

机构信息

Internal Medicine Department. Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.

School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, England.

出版信息

Clin Respir J. 2018 May;12(5):1942-1948. doi: 10.1111/crj.12762. Epub 2018 Jan 18.

DOI:10.1111/crj.12762
PMID:29316286
Abstract

BACKGROUND AND AIMS

Dyspnoea-12 assesses dyspnea based on the physical and affective components of the symptom. The aim of this study was to translate the Dyspnoea-12 into Portuguese, and to obtain validation data regarding the use of this tool in patients with chronic obstructive lung disease (COPD).

METHODS

The English version of the scale Dyspnoea-12 underwent a formal translation process into Portuguese as spoken in Brazil with the final version being called Dyspnoea-12-Pt. The latter was applied to 51 Portuguese-speaking patients with COPD (33 men; age: 66.4 ± 8.1 years; FEV : 48.7% ± 17.2% pred). Participants also completed the Medical Research Council dyspnea scale (MRC), the Baseline Dyspnea Index (BDI), the Hospital Anxiety and Depression scale, the Saint George's Respiratory Questionnaire (SGRQ) and performed spirometry and the Six-Minute Walk Test (6 MWT). Forty-five volunteers in stable clinical conditions also completed the Dyspnoea-12-Pt scale approximately 2 weeks after the first evaluation.

RESULTS

Dyspnoea-12-Pt showed significant correlations with the scales MRC (r = 0.494), BDI (r = -0.511), SGRQ (r = 0.806), Anxiety (r = 0.471), Depression (0.414) and walked distance in the 6 MWT (r = 0.329). Cronbach's alpha of Dyspnoea-12-Pt total was 0.921 and the intraclass correlation coefficient between sequential measures was 0.829.

CONCLUSION

The scale Dyspnoea-12-Pt exhibits acceptable psychometric properties and may be used as an evaluation tool of dyspnea in Portuguese speaking COPD patients.

摘要

背景与目的

呼吸困难-12量表基于症状的身体和情感成分来评估呼吸困难。本研究的目的是将呼吸困难-12量表翻译成葡萄牙语,并获取关于该工具在慢性阻塞性肺疾病(COPD)患者中使用的验证数据。

方法

将英文版的呼吸困难-12量表按照巴西葡萄牙语进行正式翻译,最终版本称为呼吸困难-12-Pt。该量表应用于51名讲葡萄牙语的COPD患者(33名男性;年龄:66.4±8.1岁;第一秒用力呼气容积:占预计值的48.7%±17.2%)。参与者还完成了医学研究委员会呼吸困难量表(MRC)、基线呼吸困难指数(BDI)、医院焦虑抑郁量表、圣乔治呼吸问卷(SGRQ),并进行了肺功能测定和六分钟步行试验(6MWT)。45名临床状况稳定的志愿者在首次评估约2周后也完成了呼吸困难-12-Pt量表。

结果

呼吸困难-12-Pt量表与MRC量表(r = 0.494)、BDI量表(r = -0.511)、SGRQ量表(r = 0.806)、焦虑量表(r = 0.471)、抑郁量表(0.414)以及6MWT中的步行距离(r = 0.329)显示出显著相关性。呼吸困难-12-Pt总量表的Cronbach's α系数为0.921,连续测量之间的组内相关系数为0.829。

结论

呼吸困难-12-Pt量表具有可接受的心理测量学特性,可作为评估讲葡萄牙语的COPD患者呼吸困难的工具。

相似文献

1
Validation of the dyspnoea-12 scale into Portuguese speaking COPD patients.将呼吸困难12量表应用于葡萄牙语COPD患者的验证。
Clin Respir J. 2018 May;12(5):1942-1948. doi: 10.1111/crj.12762. Epub 2018 Jan 18.
2
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.改良医学研究委员会量表与基线呼吸困难指数用于评估慢性阻塞性肺疾病中的呼吸困难
Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015.
3
Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的疾病严重程度阶段及影响其健康状况的因素。
Respir Med. 2000 Sep;94(9):841-6. doi: 10.1053/rmed.2000.0804.
4
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.医学研究委员会(MRC)呼吸困难量表在评估慢性阻塞性肺疾病患者残疾程度方面的实用性。
Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581.
5
Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire.《伦敦胸科日常生活活动量表》法语版及《呼吸困难-12问卷》的验证
Int J Chron Obstruct Pulmon Dis. 2018 Apr 30;13:1399-1405. doi: 10.2147/COPD.S145048. eCollection 2018.
6
Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.呼吸困难 12 量表瑞典语版在伴有心肺疾病的门诊患者中的临床验证。
BMJ Open Respir Res. 2019 Sep 18;6(1):e000418. doi: 10.1136/bmjresp-2019-000418. eCollection 2019.
7
[Relationship between degree of dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者呼吸困难程度与健康相关生活质量的关系]
Srp Arh Celok Lek. 2007 Sep-Oct;135(9-10):547-53. doi: 10.2298/sarh0710547g.
8
American translation, modification, and validation of the St. George's Respiratory Questionnaire.圣乔治呼吸问卷的美国版翻译、修改及验证
Clin Ther. 2000 Sep;22(9):1121-45. doi: 10.1016/S0149-2918(00)80089-2.
9
Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease.改良版肺功能状态与呼吸困难问卷及医学研究委员会量表在巴西慢性阻塞性肺疾病患者中的有效性验证
J Bras Pneumol. 2008 Dec;34(12):1008-18. doi: 10.1590/s1806-37132008001200005.
10
A breath of fresh air: Validity and reliability of a Portuguese version of the Multidimensional Dyspnea Profile for patients with COPD.呼吸清新空气:COPD 患者多维呼吸困难量表葡萄牙语版本的有效性和可靠性。
PLoS One. 2019 Apr 30;14(4):e0215544. doi: 10.1371/journal.pone.0215544. eCollection 2019.

引用本文的文献

1
Psychometric Validation of the Simplified Chinese Version of the Dyspnoea-12 Questionnaire for Patients with Primary Lung Cancer.原发性肺癌患者中文版简化版呼吸困难-12问卷的心理测量学验证
Healthcare (Basel). 2025 Jan 20;13(2):201. doi: 10.3390/healthcare13020201.
2
The Validity and Reliability of the Turkish version of Modified Medical Research Council Dyspnea Scale in Systemic Sclerosis Patients with Interstitial Lung Disease.改良医学研究理事会呼吸困难量表土耳其语版本在系统性硬化症合并间质性肺疾病患者中的有效性和可靠性
Thorac Res Pract. 2024 Nov 1;25(6):215-220. doi: 10.5152/ThoracResPract.2024.23135.
3
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
肌萎缩侧索硬化症/运动神经元病中的呼吸困难(呼吸急促):患病率、进展、严重程度和相关因素。
Amyotroph Lateral Scler Frontotemporal Degener. 2024 Aug;25(5-6):475-485. doi: 10.1080/21678421.2024.2322545. Epub 2024 Mar 11.
4
Adaptation and validation of the Chinese version of Dyspnoea-12 scale in individuals with chronic obstructive pulmonary disease.呼吸困难 12 量表中文版在慢性阻塞性肺疾病患者中的适应性和验证。
Clin Respir J. 2021 Oct;15(10):1081-1087. doi: 10.1111/crj.13411. Epub 2021 Jul 6.
5
Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.呼吸困难 12 量表瑞典语版在伴有心肺疾病的门诊患者中的临床验证。
BMJ Open Respir Res. 2019 Sep 18;6(1):e000418. doi: 10.1136/bmjresp-2019-000418. eCollection 2019.
6
Subjective and Objective Outcomes in Patients With COPD After Pulmonary Rehabilitation - The Impact of Comorbidities.慢性阻塞性肺疾病患者肺康复后的主观和客观结局——合并症的影响
Front Physiol. 2019 Mar 22;10:286. doi: 10.3389/fphys.2019.00286. eCollection 2019.